CCL20 underexpression
|
Multiple Myeloma
|
CCL20 underexpression
|
Multiple Myeloma
|
lenalidomide Sensitive: D – Preclinical
|
lenalidomide Sensitive: D – Preclinical
|
CCL20 underexpression
|
Multiple Myeloma
|
CCL20 underexpression
|
Multiple Myeloma
|
elotuzumab Sensitive: D – Preclinical
|
elotuzumab Sensitive: D – Preclinical
|